Drugs Made In America Acquisition II Right (DMIIR) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 79 157 sessions, December 3, 2025 to November 3, 2026
- Largest daily move
- +24.7% close of August 17, 2026
- 1-month change
- -8.2% closing prices, October 2, 2026 to November 3, 2026
Company Description
Drugs Made In America Acquisition II Right (NASDAQ: DMIIR) is classified in the blank checks industry.
DMIIR has declined 60.7% so far this year. The last closing price was $0.0550.
For FY2025, Drugs Made In America Acquisition II Right reported net income of $4.2M.
This page collects what Stock Titan holds for DMIIR, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
Drugs Made In America Acquisition II Right (DMIIR) closed at $0.0550 on November 3, 2026. So far this year, the price has lost 60.7%.
DMIIR Metrics & Rankings
Price returns through November 3, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Drugs Made In America Acquisition II Right has filed 8 recent SEC filings, including 5 Form 8-K, 2 Form 10-Q, 1 Form 10-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DMIIR SEC filings →
Financial Highlights
Drugs Made In America Acquisition II Right reported operating income of -$488K in FY2025, and net income was $4.2M. The company generated -$1.0M in operating cash flow. The current ratio was 0.09, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Drugs Made In America Acquisition II Right (DMIIR) currently stands at 6.7 thousand shares, down 42.6% from the previous reporting period. Since December 2025, short interest has increased by 1574.0%.
Days to Cover History
Days to cover for Drugs Made In America Acquisition II Right (DMIIR) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 11.7 days.
DMIIR Company Profile & Sector Positioning
Drugs Made In America Acquisition II Right (DMIIR) and is listed on the NASDAQ.